20/20 BIOLABS Sets December 9 Meeting to Approve Reverse Split & Adjourning Power—Key Vote Could Revive or Doom Company
20/20 BIOLABS INC’s urgent stockholder meeting explores reverse‑stock‑split plans and meeting‑adjourn authority—will these moves spark a turnaround or deepen its collapse?
3 minutes to read